These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 25799566

  • 21. Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
    Zhang B, Hu Y, Xiong RH, Pan YF, Xu QL, Kong XY, Cai R, Chen QQ, Tang HY, Jiang W.
    Oncotarget; 2017 Feb 21; 8(8):14078-14088. PubMed ID: 27845907
    [Abstract] [Full Text] [Related]

  • 22. Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.
    Su Z, Mao YP, Tang J, Lan XW, OuYang PY, Xie FY.
    Tumour Biol; 2016 Apr 21; 37(4):4429-38. PubMed ID: 26499947
    [Abstract] [Full Text] [Related]

  • 23. Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
    Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, Sun Y, Chen XZ, Li JG, Zhu XD, Hu CS, Xu XY, Chen YY, Hu WH, Guo L, Mo HY, Chen L, Mao YP, Sun R, Ai P, Liang SB, Long GX, Zheng BM, Feng XL, Gong XC, Li L, Shen CY, Xu JY, Guo Y, Chen YM, Zhang F, Lin L, Tang LL, Liu MZ, Ma J, Sun Y.
    Int J Cancer; 2019 Jul 01; 145(1):295-305. PubMed ID: 30613964
    [Abstract] [Full Text] [Related]

  • 24. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
    Lan XW, Zou XB, Xiao Y, Tang J, OuYang PY, Su Z, Xie FY.
    PLoS One; 2016 Jul 01; 11(8):e0160758. PubMed ID: 27509025
    [Abstract] [Full Text] [Related]

  • 25. Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma.
    Zhang W, Dou H, Lam C, Liu J, Zhou J, Liu Y, Wang X.
    Tumour Biol; 2013 Jun 01; 34(3):1729-36. PubMed ID: 23436047
    [Abstract] [Full Text] [Related]

  • 26. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
    Li Y, Chen QY, Tang LQ, Liu LT, Guo SS, Guo L, Mo HY, Chen MY, Guo X, Cao KJ, Qian CN, Zeng MS, Bei JX, Shao JY, Sun Y, Tan J, Chen S, Ma J, Zhao C, Mai HQ.
    BMC Cancer; 2017 Aug 24; 17(1):567. PubMed ID: 28836950
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy and intensity-modulated radiotherapy alone for stage II nasopharyngeal carcinoma.
    Chen KH, Zhu XD, Li L, Qu S, Liang ZQ, Liang X, Pan XB, Liang ZG, Jiang YM.
    Oncotarget; 2016 Oct 18; 7(42):69041-69050. PubMed ID: 27634892
    [Abstract] [Full Text] [Related]

  • 28. Which treatment is better than concurrent chemoradiotherapy about survival for stage III or IV locally advanced nasopharyngeal carcinoma? An updated Bayesian network meta-analysis of randomized controlled trials.
    Fang L, Shi L, Wang W, Hu T, Rao X.
    Eur Arch Otorhinolaryngol; 2021 Oct 18; 278(10):3633-3642. PubMed ID: 33598731
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Kong L, Zhang Y, Hu C, Guo Y, Lu JJ.
    Cancer; 2017 Jun 15; 123(12):2258-2267. PubMed ID: 28192641
    [Abstract] [Full Text] [Related]

  • 33. Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective study.
    Li SW, Wang H, Liu ML, Zhang HB, Xiang YQ, Lv X, Xia WX, Zeng MS, Mai HQ, Hong MH, Guo X.
    Med Oncol; 2013 Mar 15; 30(1):322. PubMed ID: 23254962
    [Abstract] [Full Text] [Related]

  • 34. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Zhou R, Zhu J, Chen X, Liu Y, Wang Y, Zhang T.
    Clin Transl Oncol; 2020 Mar 15; 22(3):429-439. PubMed ID: 31165410
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis.
    Li Y, Tang LQ, Liu LT, Guo SS, Liang YJ, Sun XS, Tang QN, Bei JX, Tan J, Chen S, Ma J, Zhao C, Chen QY, Mai HQ.
    Cancer Res Treat; 2018 Oct 15; 50(4):1304-1315. PubMed ID: 29334605
    [Abstract] [Full Text] [Related]

  • 37. Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma.
    Liao K, Tao HY, Zhan ZJ, Qiu WZ, Zheng RH.
    Oncol Res Treat; 2021 Oct 15; 44(11):602-612. PubMed ID: 34601467
    [Abstract] [Full Text] [Related]

  • 38. Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma.
    Komatsu M, Tsukuda M, Matsuda H, Horiuchi C, Taguch T, Takahashi M, Nishimura G, Mori M, Niho T, Ishitoya J, Sakuma Y, Hirama M, Shiono O.
    Anticancer Res; 2012 Feb 15; 32(2):681-6. PubMed ID: 22287763
    [Abstract] [Full Text] [Related]

  • 39. The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT.
    Xu T, Shen C, Ou X, He X, Ying H, Hu C.
    Oncotarget; 2016 Apr 12; 7(15):21013-22. PubMed ID: 26942700
    [Abstract] [Full Text] [Related]

  • 40. [Effects of Different Chemoradiotherapy Regimens on Early Survival Outcomes in Patients with Locally Advanced Nasopharyngeal Carcinoma].
    Li N, Li P.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Sep 12; 51(5):702-707. PubMed ID: 32975088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.